Investment
Features
FeesSafety
Academy
More
Pluang+

Weight loss ETF THNR rebalances index, adding Structure Therapeutics and adjusting key drugmakers' weights.

Market News
25 Mar 2026
ETF Trends
View Source
Bullish
pluang ai news

The Amplify Weight Loss Drug & Treatment ETF (THNR) recently rebalanced its index, adding Structure Therapeutics Inc and removing Hims & Hers Health Inc. The index, which tracks companies involved in GLP-1 weight loss drugs, adjusted weights for several major holdings: AstraZeneca increased from 5.3% to 7.1%, Novo Nordisk and Arrowhead Pharmaceuticals also rose, while Eli Lilly dropped from 12.4% to 10.5%. These changes reflect the evolving market for weight loss treatments and aim to provide targeted exposure to this growing sector.

More News (HIMS)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App